RUBIUS THERAPEUTICS, INC.
CIK 0001709401
Revenue (TTM)
$0
FY Jan 2023
Net Income (TTM)
−$208.54M
+8.6% YoY
FY Jan 2023
EPS Diluted (TTM)
−$2.30
+10.8% YoY
FY Jan 2023
Gross Margin
—
FY Jan 2023
Operating Margin
—
FY Jan 2023
Net Margin
—
FY Jan 2023
Free Cash Flow (TTM)
−$158.93M
FY Jan 2023
Cash
$14.87M
FY Jan 2023
Total Debt
$0
FY Jan 2023
Shares Outstanding
90.4M sh
FY Jan 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.